Franklin Resources Reduces Stake in Amgen

Asset manager cuts position in biotech firm by 11.8% in Q3

Mar. 12, 2026 at 10:34am

Got story updates? Submit your updates here. ›

Franklin Resources Inc. has reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 11.8% in the third quarter, according to a recent SEC filing. The asset management firm now owns 2,642,072 shares of the medical research company's stock, down from 2,994,117 shares held previously.

Why it matters

Amgen is one of the largest biotechnology companies in the world, with a diverse portfolio of drugs used in oncology, nephrology, and other therapeutic areas. Changes in major institutional ownership of the stock can signal shifts in investor sentiment and influence the stock price.

The details

According to the filing, Franklin Resources sold 352,045 shares of Amgen during the third quarter. The firm now owns approximately 0.49% of Amgen's outstanding shares, down from 0.56% previously. Amgen's stock price has risen steadily over the past year, up around 20% as the company has continued to grow its revenues and earnings.

  • Franklin Resources filed the 13F disclosure with the SEC on March 12, 2026, reporting its Q3 2025 holdings.

The players

Franklin Resources Inc.

A global investment management organization that provides a range of investment management services to institutional and individual investors.

Amgen Inc.

A multinational biopharmaceutical company that discovers, develops, manufactures, and delivers human therapeutics.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Franklin Resources' Amgen stake reflects broader shifts in institutional ownership of the stock, which could impact the share price going forward. Investors will be watching to see if other major holders make similar moves or if Franklin Resources continues to trim its position.